Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate.

MLA

Illidge, T. M., et al. “Malignant Hypercalcaemia in Pregnancy and Antenatal Administration of Intravenous Pamidronate.” Clinical Oncology (Royal College of Radiologists (Great Britain)), vol. 8, no. 4, 1996, pp. 257–58. EBSCOhost, https://doi.org/10.1016/s0936-6555(05)80667-3.

APA

Illidge, T. M., Hussey, M., & Godden, C. W. (1996). Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate. Clinical Oncology (Royal College of Radiologists (Great Britain)), 8(4), 257–258. https://doi.org/10.1016/s0936-6555(05)80667-3

Chicago

Illidge, T M, M Hussey, and C W Godden. 1996. “Malignant Hypercalcaemia in Pregnancy and Antenatal Administration of Intravenous Pamidronate.” Clinical Oncology (Royal College of Radiologists (Great Britain)) 8 (4): 257–58. doi:10.1016/s0936-6555(05)80667-3.